YungShin Global Holding Corporation (TPE:3705)
Taiwan · Delayed Price · Currency is TWD 57.00
-0.20 (-0.35%)
Jan 13, 2026, 10:02 AM CST
YungShin Global Holding Market Cap
YungShin Global Holding has a market cap or net worth of 15.24 billion as of January 12, 2026. Its market cap has increased by 5.54% in one year.
Market Cap
15.24B
Enterprise Value
15.15B
Revenue
8.37B
Ranking
n/a
PE Ratio
15.82
Stock Price
57.00
Market Cap Chart
Since January 4, 2011, YungShin Global Holding's market cap has increased from 10.25B to 15.24B, an increase of 48.66%. That is a compound annual growth rate of 2.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 15.29B | 0.70% |
| Dec 31, 2025 | 15.18B | 5.75% |
| Dec 31, 2024 | 14.36B | 15.91% |
| Dec 29, 2023 | 12.39B | 1.09% |
| Dec 30, 2022 | 12.25B | 7.10% |
| Dec 30, 2021 | 11.44B | -3.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 189.36B |
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals Co., LTD. | 64.12B |
| Heron Neutron Medical | 59.70B |
| Oneness Biotech | 33.15B |
| Lumosa Therapeutics | 31.67B |
| Center Laboratories | 30.53B |